Skip to main content
. 2017 Jun 19;14(2):2081–2088. doi: 10.3892/ol.2017.6416

Figure 2.

Figure 2.

Cell cycle analysis of bladder cancer cells treated with oncolytic Ad5-UPII-E1A, or with Ad5-UPII-E1A and MMC or HCPT. (A) A total of 5,637 cells treated with Ad5-UPII-E1A alone, Ad5-UPII-E1A combined with MMC or combined with HCPT for 48, 72 and 96 h. (B) Quantification of the cell cycle analysis results. Data are presented as the mean ± standard deviation of three independent experiments. *P<0.05 vs. Ad5-UPII-E1A alone group. Ad5-UPII-E1A, urothelium-specific recombinant adenovirus type 5; MMC, mitomycin; HCPT, hydroxycamptothecin.